Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
Copyright European Union. (1)
European, Industry news, News 22/10/2024

EU Council Approves Modernised Design Protection Package

AgriTech and Intellectual Property
Industry news, News 17/10/2024

AgriTech and Intellectual Property

Secerna Interior Shots September 2024 002
Industry news, News, Team news 08/10/2024

Secerna LLP Strengthens Chemistry & Pharmaceutical Team with New Patent Attorney

Mpox: Emerging Challenges and Pharmaceutical Innovations in the Face of a Global Health Crisis (Main)
Industry news, News 07/10/2024

Mpox: Emerging Challenges and Pharmaceutical Innovations in the Face of a Global Health Crisis

Navigating Employee Inventor Rights
Industry news, News 30/09/2024

Navigating Employee Inventor Rights

Secerna Highlights IP Importance on "Why Small Business Matters" Podcast
Events, Industry news, News 25/09/2024

Secerna Highlights IP Importance on "Why Small Business Matters" Podcast

Morning Sickness Drugs Repurposing
News 17/09/2024

Morning Sickness: The Role of Drug Repurposing and Intellectual Property Considerations

Charlotte Cell & Gene Meeting On The Mesa
Events, News 17/09/2024

Secerna to attend Cell & Gene Meeting on the Mesa in Phoenix, USA

John, Jon NEPIC
Events, News, Team news 17/09/2024

Secerna to attend NEPIC Meet the Members Expo 2024

3 4 5 6 7 8 9 10 11 12 13